Quantamental Technologies LLC Novo Nordisk A S Transaction History

Quantamental Technologies LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $1.07 Million - $1.18 Million	6,832 New	6,832 $1.11 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $638,757 - $783,898	-6,704 Reduced 68.95%	3,019 $301,000
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $1 Million - $1.18 Million	9,723 New	9,723 $1.08 Million
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $856,520 - $1.04 Million	-9,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $882,096 - $1.08 Million	9,200 New	9,200 $1.03 Million
Q2 2021 Aug 16, 2021	SELL	$67.66 - $84.76 $298,109 - $373,452	-4,406 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $295,466 - $334,062	4,406 New	4,406 $297,000
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $657,790 - $725,232	-10,328 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $604,601 - $701,684	10,328 New	10,328 $676,000
Q2 2019 Aug 12, 2019	SELL	$46.79 - $52.47 $36,309 - $40,716	-776 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$46.36 - $52.63 $35,975 - $40,840	776 New	776 $41,000

1,955

318M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.